PPARA and obesity due to melanocortin 4 receptor deficiency: These substances can increase the risk of cardiovascular diseases, obesity, insulin resistance, type 2 diabetes and cancer by altering normal hormonal activity and activating nuclear receptors such as PPAR α, β y γ, and the retinoid X receptor, which control various aspects of energy metabolism, inflammation, and cellular homeostasis (63, 64).